Skip to content
Clinical Trials – home

Diahaza s.r.o.

Research siteFast reply

Czechia Palackeho 492/62, 769 01 Zlin, Czechia

  • 1 trial recruiting
  • Obesity · Diabetic neuropathy · Overweight
  • Adult patients

About Specializations

Diahaza s.r.o. in Zlin, Czechia specialises in clinical trials of conditions such as Obesity, Diabetic neuropathy, Overweight, Pain, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Chronic Pain Research

At Diahaza s.r.o., the Neurology program includes research focused on chronic pain due to diabetic peripheral neuropathy. These studies are aimed at understanding whether new treatment options can better relieve nerve-related pain and improve day-to-day comfort for people living with diabetes.

  • Chronic pain linked to diabetic peripheral neuropathy
  • Evaluation of a new therapy for nerve pain relief
  • Improving treatment effectiveness for nervous system diseases

This area reflects a practical effort to address difficult-to-treat pain conditions within neurological care.

Nutritional and Metabolic Diseases in Obesity Research

The site is also active in studies of obesity and overweight, with a strong focus on therapies that may support meaningful weight reduction and better long-term health outcomes. These trials are designed to test whether new treatments can help people manage body weight more effectively and address related metabolic risks.

  • Obesity and overweight
  • Testing new approaches for weight management
  • Assessing treatment benefit in metabolic disease

Research in this field combines weight-focused care with broader attention to health conditions often linked to excess body weight.

Cardiometabolic Outcomes and Diabetes-Related Health

Clinical research at Diahaza s.r.o. also examines how new treatments may influence broader health outcomes in people with obesity or overweight, including effects on heart and kidney health as well as blood sugar control. The purpose of these studies is to evaluate whether emerging therapies can improve overall disease management beyond weight loss alone.

  • Heart-related health outcomes
  • Kidney function and kidney outcomes
  • Blood sugar control in people with obesity or diabetes

This research connects endocrine and cardiovascular interests, supporting a wider view of metabolic health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Palackeho 492/62769 01 ZlinCzechia
Recruiting now
1 trial
Conditions studied
5

More sites in ZlinCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Obesity+1

Recruiting

A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.